# 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

> **NCT01157351** · PHASE4 · COMPLETED · sponsor: **Janssen Scientific Affairs, LLC** · enrollment: 450 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** paliperidone
- **DRUG:** risperidone
- **DRUG:** haloperidole
- **DRUG:** perphenazine
- **DRUG:** aripiprazole
- **DRUG:** quetiapine
- **DRUG:** paliperidone palmitate
- **DRUG:** olanzapine

## Key facts

- **NCT ID:** NCT01157351
- **Lead sponsor:** Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157351, "15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01157351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*